nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC1—Vemurafenib—melanoma	0.141	0.26	CbGbCtD
Lamivudine—ABCB1—melanoma	0.122	1	CbGaD
Lamivudine—ABCG2—Vemurafenib—melanoma	0.0942	0.174	CbGbCtD
Lamivudine—ABCC1—Dactinomycin—melanoma	0.0935	0.173	CbGbCtD
Lamivudine—ABCG2—Dactinomycin—melanoma	0.0626	0.116	CbGbCtD
Lamivudine—ABCC1—Docetaxel—melanoma	0.0483	0.0892	CbGbCtD
Lamivudine—ABCC2—Docetaxel—melanoma	0.0357	0.066	CbGbCtD
Lamivudine—ABCG2—Docetaxel—melanoma	0.0323	0.0597	CbGbCtD
Lamivudine—ABCB1—Dactinomycin—melanoma	0.0226	0.0417	CbGbCtD
Lamivudine—ABCB1—Docetaxel—melanoma	0.0117	0.0215	CbGbCtD
Lamivudine—CMPK1—hair follicle—melanoma	0.00406	0.0739	CbGeAlD
Lamivudine—NME1-NME2—eye—melanoma	0.00362	0.0658	CbGeAlD
Lamivudine—PGK1—skin of body—melanoma	0.00345	0.0628	CbGeAlD
Lamivudine—NT5C—eye—melanoma	0.00335	0.061	CbGeAlD
Lamivudine—NME1—neck—melanoma	0.00283	0.0514	CbGeAlD
Lamivudine—PCYT2—head—melanoma	0.00262	0.0477	CbGeAlD
Lamivudine—PGK1—head—melanoma	0.00225	0.041	CbGeAlD
Lamivudine—NME1-NME2—head—melanoma	0.00205	0.0373	CbGeAlD
Lamivudine—NME2—eye—melanoma	0.00198	0.036	CbGeAlD
Lamivudine—NME2—retina—melanoma	0.00196	0.0357	CbGeAlD
Lamivudine—NT5C—head—melanoma	0.0019	0.0346	CbGeAlD
Lamivudine—NME1—skin of body—melanoma	0.00183	0.0333	CbGeAlD
Lamivudine—PCYT1A—head—melanoma	0.00179	0.0325	CbGeAlD
Lamivudine—CMPK1—skin of body—melanoma	0.00176	0.0321	CbGeAlD
Lamivudine—NME1-NME2—lymph node—melanoma	0.00144	0.0261	CbGeAlD
Lamivudine—ABCC1—hair follicle—melanoma	0.00136	0.0248	CbGeAlD
Lamivudine—NT5C—lymph node—melanoma	0.00133	0.0242	CbGeAlD
Lamivudine—NME1—head—melanoma	0.00119	0.0217	CbGeAlD
Lamivudine—CMPK1—head—melanoma	0.00115	0.0209	CbGeAlD
Lamivudine—NME2—head—melanoma	0.00112	0.0205	CbGeAlD
Lamivudine—DCK—retina—melanoma	0.001	0.0182	CbGeAlD
Lamivudine—NME1—lymph node—melanoma	0.000836	0.0152	CbGeAlD
Lamivudine—CMPK1—lymph node—melanoma	0.000806	0.0147	CbGeAlD
Lamivudine—DCK—mammalian vulva—melanoma	0.000801	0.0146	CbGeAlD
Lamivudine—NME2—lymph node—melanoma	0.000788	0.0143	CbGeAlD
Lamivudine—SLC22A3—mammalian vulva—melanoma	0.000653	0.0119	CbGeAlD
Lamivudine—DCK—head—melanoma	0.000573	0.0104	CbGeAlD
Lamivudine—ABCC3—head—melanoma	0.000549	0.00998	CbGeAlD
Lamivudine—ABCC1—mammalian vulva—melanoma	0.00054	0.00982	CbGeAlD
Lamivudine—ABCB1—blood vessel—melanoma	0.000522	0.00949	CbGeAlD
Lamivudine—SLC22A1—head—melanoma	0.000489	0.00889	CbGeAlD
Lamivudine—SLC22A3—head—melanoma	0.000467	0.00849	CbGeAlD
Lamivudine—ABCC4—head—melanoma	0.000453	0.00824	CbGeAlD
Lamivudine—ABCG2—mammalian vulva—melanoma	0.000447	0.00813	CbGeAlD
Lamivudine—DCK—lymph node—melanoma	0.000401	0.0073	CbGeAlD
Lamivudine—ABCC3—lymph node—melanoma	0.000384	0.00699	CbGeAlD
Lamivudine—Connective tissue disorder—Carmustine—melanoma	0.000356	0.00279	CcSEcCtD
Lamivudine—Renal impairment—Docetaxel—melanoma	0.000354	0.00277	CcSEcCtD
Lamivudine—Hepatitis—Temozolomide—melanoma	0.00035	0.00274	CcSEcCtD
Lamivudine—Asthenia—Vemurafenib—melanoma	0.000349	0.00273	CcSEcCtD
Lamivudine—Hypoaesthesia—Temozolomide—melanoma	0.000348	0.00273	CcSEcCtD
Lamivudine—Pharyngitis—Temozolomide—melanoma	0.000347	0.00272	CcSEcCtD
Lamivudine—Chills—Dactinomycin—melanoma	0.000347	0.00272	CcSEcCtD
Lamivudine—Pruritus—Vemurafenib—melanoma	0.000344	0.0027	CcSEcCtD
Lamivudine—Connective tissue disorder—Temozolomide—melanoma	0.000344	0.00269	CcSEcCtD
Lamivudine—Alopecia—Dactinomycin—melanoma	0.000342	0.00268	CcSEcCtD
Lamivudine—Erythema—Dactinomycin—melanoma	0.000337	0.00264	CcSEcCtD
Lamivudine—Ill-defined disorder—Bleomycin—melanoma	0.000335	0.00262	CcSEcCtD
Lamivudine—Anaemia—Bleomycin—melanoma	0.000334	0.00261	CcSEcCtD
Lamivudine—Diarrhoea—Vemurafenib—melanoma	0.000333	0.00261	CcSEcCtD
Lamivudine—Migraine—Docetaxel—melanoma	0.000331	0.00259	CcSEcCtD
Lamivudine—Erythema multiforme—Temozolomide—melanoma	0.000331	0.00259	CcSEcCtD
Lamivudine—SLC22A3—lymph node—melanoma	0.000327	0.00595	CbGeAlD
Lamivudine—Malaise—Bleomycin—melanoma	0.000326	0.00255	CcSEcCtD
Lamivudine—Leukopenia—Bleomycin—melanoma	0.000323	0.00253	CcSEcCtD
Lamivudine—Dizziness—Vemurafenib—melanoma	0.000322	0.00252	CcSEcCtD
Lamivudine—Alopecia—Carmustine—melanoma	0.00032	0.00251	CcSEcCtD
Lamivudine—ABCC4—lymph node—melanoma	0.000317	0.00577	CbGeAlD
Lamivudine—Immune system disorder—Temozolomide—melanoma	0.000316	0.00248	CcSEcCtD
Lamivudine—Mediastinal disorder—Temozolomide—melanoma	0.000316	0.00247	CcSEcCtD
Lamivudine—Malnutrition—Carmustine—melanoma	0.000315	0.00247	CcSEcCtD
Lamivudine—Erythema—Carmustine—melanoma	0.000315	0.00247	CcSEcCtD
Lamivudine—Cough—Bleomycin—melanoma	0.000315	0.00247	CcSEcCtD
Lamivudine—Chills—Temozolomide—melanoma	0.000314	0.00246	CcSEcCtD
Lamivudine—Dehydration—Docetaxel—melanoma	0.000313	0.00245	CcSEcCtD
Lamivudine—Ill-defined disorder—Dactinomycin—melanoma	0.000313	0.00245	CcSEcCtD
Lamivudine—Anaemia—Dactinomycin—melanoma	0.000311	0.00244	CcSEcCtD
Lamivudine—Liver function test abnormal—Docetaxel—melanoma	0.000311	0.00243	CcSEcCtD
Lamivudine—Vomiting—Vemurafenib—melanoma	0.000309	0.00242	CcSEcCtD
Lamivudine—Alopecia—Temozolomide—melanoma	0.000309	0.00242	CcSEcCtD
Lamivudine—Chest pain—Bleomycin—melanoma	0.000308	0.00241	CcSEcCtD
Lamivudine—Myalgia—Bleomycin—melanoma	0.000308	0.00241	CcSEcCtD
Lamivudine—Abdominal pain upper—Docetaxel—melanoma	0.000307	0.00241	CcSEcCtD
Lamivudine—ABCC2—lymph node—melanoma	0.000307	0.00558	CbGeAlD
Lamivudine—Rash—Vemurafenib—melanoma	0.000307	0.0024	CcSEcCtD
Lamivudine—Dermatitis—Vemurafenib—melanoma	0.000307	0.0024	CcSEcCtD
Lamivudine—Back pain—Carmustine—melanoma	0.000305	0.00239	CcSEcCtD
Lamivudine—Headache—Vemurafenib—melanoma	0.000305	0.00239	CcSEcCtD
Lamivudine—Erythema—Temozolomide—melanoma	0.000305	0.00239	CcSEcCtD
Lamivudine—Malnutrition—Temozolomide—melanoma	0.000305	0.00239	CcSEcCtD
Lamivudine—Discomfort—Bleomycin—melanoma	0.000304	0.00238	CcSEcCtD
Lamivudine—Malaise—Dactinomycin—melanoma	0.000304	0.00238	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000303	0.00237	CcSEcCtD
Lamivudine—Cramp muscle—Docetaxel—melanoma	0.000303	0.00237	CcSEcCtD
Lamivudine—Leukopenia—Dactinomycin—melanoma	0.000302	0.00236	CcSEcCtD
Lamivudine—Nasopharyngitis—Docetaxel—melanoma	0.000301	0.00236	CcSEcCtD
Lamivudine—Dysgeusia—Temozolomide—melanoma	0.000298	0.00234	CcSEcCtD
Lamivudine—Confusional state—Bleomycin—melanoma	0.000297	0.00233	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000297	0.00232	CcSEcCtD
Lamivudine—Tremor—Carmustine—melanoma	0.000295	0.00231	CcSEcCtD
Lamivudine—Oedema—Bleomycin—melanoma	0.000295	0.00231	CcSEcCtD
Lamivudine—Anaphylactic shock—Bleomycin—melanoma	0.000295	0.00231	CcSEcCtD
Lamivudine—Back pain—Temozolomide—melanoma	0.000295	0.00231	CcSEcCtD
Lamivudine—Infection—Bleomycin—melanoma	0.000293	0.00229	CcSEcCtD
Lamivudine—Anaemia—Carmustine—melanoma	0.000292	0.00228	CcSEcCtD
Lamivudine—Dysphagia—Docetaxel—melanoma	0.000291	0.00228	CcSEcCtD
Lamivudine—Nausea—Vemurafenib—melanoma	0.000289	0.00226	CcSEcCtD
Lamivudine—Thrombocytopenia—Bleomycin—melanoma	0.000289	0.00226	CcSEcCtD
Lamivudine—Myalgia—Dactinomycin—melanoma	0.000287	0.00225	CcSEcCtD
Lamivudine—Tremor—Temozolomide—melanoma	0.000286	0.00224	CcSEcCtD
Lamivudine—Discomfort—Dactinomycin—melanoma	0.000283	0.00222	CcSEcCtD
Lamivudine—Ill-defined disorder—Temozolomide—melanoma	0.000283	0.00221	CcSEcCtD
Lamivudine—Leukopenia—Carmustine—melanoma	0.000282	0.00221	CcSEcCtD
Lamivudine—Anaemia—Temozolomide—melanoma	0.000282	0.0022	CcSEcCtD
Lamivudine—Anorexia—Bleomycin—melanoma	0.000281	0.0022	CcSEcCtD
Lamivudine—Angioedema—Temozolomide—melanoma	0.000278	0.00218	CcSEcCtD
Lamivudine—Pancytopenia—Docetaxel—melanoma	0.000276	0.00216	CcSEcCtD
Lamivudine—Hypotension—Bleomycin—melanoma	0.000276	0.00216	CcSEcCtD
Lamivudine—ABCB1—retina—melanoma	0.000275	0.005	CbGeAlD
Lamivudine—Oedema—Dactinomycin—melanoma	0.000275	0.00215	CcSEcCtD
Lamivudine—Malaise—Temozolomide—melanoma	0.000275	0.00215	CcSEcCtD
Lamivudine—Vertigo—Temozolomide—melanoma	0.000274	0.00214	CcSEcCtD
Lamivudine—Convulsion—Carmustine—melanoma	0.000273	0.00214	CcSEcCtD
Lamivudine—Infection—Dactinomycin—melanoma	0.000273	0.00214	CcSEcCtD
Lamivudine—Leukopenia—Temozolomide—melanoma	0.000273	0.00214	CcSEcCtD
Lamivudine—Neutropenia—Docetaxel—melanoma	0.000272	0.00213	CcSEcCtD
Lamivudine—ABCC1—lymph node—melanoma	0.00027	0.00492	CbGeAlD
Lamivudine—Thrombocytopenia—Dactinomycin—melanoma	0.000269	0.00211	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000269	0.0021	CcSEcCtD
Lamivudine—Chest pain—Carmustine—melanoma	0.000269	0.0021	CcSEcCtD
Lamivudine—Myalgia—Carmustine—melanoma	0.000269	0.0021	CcSEcCtD
Lamivudine—Anxiety—Carmustine—melanoma	0.000268	0.00209	CcSEcCtD
Lamivudine—Cough—Temozolomide—melanoma	0.000266	0.00208	CcSEcCtD
Lamivudine—Paraesthesia—Bleomycin—melanoma	0.000265	0.00207	CcSEcCtD
Lamivudine—Convulsion—Temozolomide—melanoma	0.000264	0.00207	CcSEcCtD
Lamivudine—Dyspnoea—Bleomycin—melanoma	0.000263	0.00206	CcSEcCtD
Lamivudine—Anorexia—Dactinomycin—melanoma	0.000262	0.00205	CcSEcCtD
Lamivudine—Confusional state—Carmustine—melanoma	0.00026	0.00203	CcSEcCtD
Lamivudine—Myalgia—Temozolomide—melanoma	0.000259	0.00203	CcSEcCtD
Lamivudine—Arthralgia—Temozolomide—melanoma	0.000259	0.00203	CcSEcCtD
Lamivudine—Anxiety—Temozolomide—melanoma	0.000259	0.00202	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000258	0.00202	CcSEcCtD
Lamivudine—Oedema—Carmustine—melanoma	0.000257	0.00201	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000257	0.00201	CcSEcCtD
Lamivudine—Discomfort—Temozolomide—melanoma	0.000256	0.00201	CcSEcCtD
Lamivudine—Decreased appetite—Bleomycin—melanoma	0.000256	0.00201	CcSEcCtD
Lamivudine—Infection—Carmustine—melanoma	0.000256	0.002	CcSEcCtD
Lamivudine—Renal failure—Docetaxel—melanoma	0.000255	0.002	CcSEcCtD
Lamivudine—Neuropathy peripheral—Docetaxel—melanoma	0.000254	0.00199	CcSEcCtD
Lamivudine—Dry mouth—Temozolomide—melanoma	0.000254	0.00199	CcSEcCtD
Lamivudine—Jaundice—Docetaxel—melanoma	0.000253	0.00198	CcSEcCtD
Lamivudine—Stomatitis—Docetaxel—melanoma	0.000253	0.00198	CcSEcCtD
Lamivudine—Pain—Bleomycin—melanoma	0.000252	0.00197	CcSEcCtD
Lamivudine—Thrombocytopenia—Carmustine—melanoma	0.000252	0.00197	CcSEcCtD
Lamivudine—Confusional state—Temozolomide—melanoma	0.000251	0.00196	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000251	0.00196	CcSEcCtD
Lamivudine—Oedema—Temozolomide—melanoma	0.000249	0.00195	CcSEcCtD
Lamivudine—Anaphylactic shock—Temozolomide—melanoma	0.000249	0.00195	CcSEcCtD
Lamivudine—Infection—Temozolomide—melanoma	0.000247	0.00193	CcSEcCtD
Lamivudine—Anorexia—Carmustine—melanoma	0.000245	0.00192	CcSEcCtD
Lamivudine—Hepatobiliary disease—Docetaxel—melanoma	0.000245	0.00192	CcSEcCtD
Lamivudine—Epistaxis—Docetaxel—melanoma	0.000245	0.00191	CcSEcCtD
Lamivudine—Nervous system disorder—Temozolomide—melanoma	0.000244	0.00191	CcSEcCtD
Lamivudine—Thrombocytopenia—Temozolomide—melanoma	0.000244	0.00191	CcSEcCtD
Lamivudine—Feeling abnormal—Bleomycin—melanoma	0.000243	0.0019	CcSEcCtD
Lamivudine—Agranulocytosis—Docetaxel—melanoma	0.000242	0.00189	CcSEcCtD
Lamivudine—Skin disorder—Temozolomide—melanoma	0.000242	0.00189	CcSEcCtD
Lamivudine—Hypotension—Carmustine—melanoma	0.000241	0.00188	CcSEcCtD
Lamivudine—Hyperhidrosis—Temozolomide—melanoma	0.00024	0.00188	CcSEcCtD
Lamivudine—Decreased appetite—Dactinomycin—melanoma	0.000239	0.00187	CcSEcCtD
Lamivudine—Fatigue—Dactinomycin—melanoma	0.000237	0.00186	CcSEcCtD
Lamivudine—Anorexia—Temozolomide—melanoma	0.000237	0.00186	CcSEcCtD
Lamivudine—Pain—Dactinomycin—melanoma	0.000235	0.00184	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Carmustine—melanoma	0.000235	0.00184	CcSEcCtD
Lamivudine—Urticaria—Bleomycin—melanoma	0.000234	0.00183	CcSEcCtD
Lamivudine—Rhinitis—Docetaxel—melanoma	0.000233	0.00183	CcSEcCtD
Lamivudine—Body temperature increased—Bleomycin—melanoma	0.000233	0.00182	CcSEcCtD
Lamivudine—Hepatitis—Docetaxel—melanoma	0.000233	0.00182	CcSEcCtD
Lamivudine—Insomnia—Carmustine—melanoma	0.000233	0.00182	CcSEcCtD
Lamivudine—Hypoaesthesia—Docetaxel—melanoma	0.000232	0.00181	CcSEcCtD
Lamivudine—Paraesthesia—Carmustine—melanoma	0.000231	0.00181	CcSEcCtD
Lamivudine—Pharyngitis—Docetaxel—melanoma	0.000231	0.00181	CcSEcCtD
Lamivudine—Dyspnoea—Carmustine—melanoma	0.000229	0.0018	CcSEcCtD
Lamivudine—Somnolence—Carmustine—melanoma	0.000229	0.00179	CcSEcCtD
Lamivudine—Connective tissue disorder—Docetaxel—melanoma	0.000229	0.00179	CcSEcCtD
Lamivudine—Feeling abnormal—Dactinomycin—melanoma	0.000227	0.00177	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000227	0.00177	CcSEcCtD
Lamivudine—Insomnia—Temozolomide—melanoma	0.000225	0.00176	CcSEcCtD
Lamivudine—Gastrointestinal pain—Dactinomycin—melanoma	0.000225	0.00176	CcSEcCtD
Lamivudine—ABCG2—lymph node—melanoma	0.000224	0.00407	CbGeAlD
Lamivudine—Decreased appetite—Carmustine—melanoma	0.000224	0.00175	CcSEcCtD
Lamivudine—Paraesthesia—Temozolomide—melanoma	0.000223	0.00175	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Carmustine—melanoma	0.000222	0.00174	CcSEcCtD
Lamivudine—Dyspnoea—Temozolomide—melanoma	0.000222	0.00174	CcSEcCtD
Lamivudine—Somnolence—Temozolomide—melanoma	0.000221	0.00173	CcSEcCtD
Lamivudine—ABCB1—mammalian vulva—melanoma	0.00022	0.00401	CbGeAlD
Lamivudine—Erythema multiforme—Docetaxel—melanoma	0.00022	0.00172	CcSEcCtD
Lamivudine—Pain—Carmustine—melanoma	0.00022	0.00172	CcSEcCtD
Lamivudine—Constipation—Carmustine—melanoma	0.00022	0.00172	CcSEcCtD
Lamivudine—Dyspepsia—Temozolomide—melanoma	0.000219	0.00171	CcSEcCtD
Lamivudine—Abdominal pain—Dactinomycin—melanoma	0.000217	0.0017	CcSEcCtD
Lamivudine—Body temperature increased—Dactinomycin—melanoma	0.000217	0.0017	CcSEcCtD
Lamivudine—Hypersensitivity—Bleomycin—melanoma	0.000217	0.0017	CcSEcCtD
Lamivudine—Decreased appetite—Temozolomide—melanoma	0.000216	0.00169	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Temozolomide—melanoma	0.000215	0.00168	CcSEcCtD
Lamivudine—Fatigue—Temozolomide—melanoma	0.000214	0.00168	CcSEcCtD
Lamivudine—Pain—Temozolomide—melanoma	0.000213	0.00166	CcSEcCtD
Lamivudine—Constipation—Temozolomide—melanoma	0.000213	0.00166	CcSEcCtD
Lamivudine—Feeling abnormal—Carmustine—melanoma	0.000212	0.00166	CcSEcCtD
Lamivudine—Asthenia—Bleomycin—melanoma	0.000212	0.00166	CcSEcCtD
Lamivudine—Gastrointestinal pain—Carmustine—melanoma	0.00021	0.00165	CcSEcCtD
Lamivudine—Immune system disorder—Docetaxel—melanoma	0.00021	0.00165	CcSEcCtD
Lamivudine—Mediastinal disorder—Docetaxel—melanoma	0.00021	0.00164	CcSEcCtD
Lamivudine—Chills—Docetaxel—melanoma	0.000209	0.00164	CcSEcCtD
Lamivudine—Pruritus—Bleomycin—melanoma	0.000209	0.00163	CcSEcCtD
Lamivudine—Alopecia—Docetaxel—melanoma	0.000206	0.00161	CcSEcCtD
Lamivudine—Feeling abnormal—Temozolomide—melanoma	0.000205	0.0016	CcSEcCtD
Lamivudine—Body temperature increased—Carmustine—melanoma	0.000203	0.00159	CcSEcCtD
Lamivudine—Abdominal pain—Carmustine—melanoma	0.000203	0.00159	CcSEcCtD
Lamivudine—Gastrointestinal pain—Temozolomide—melanoma	0.000203	0.00159	CcSEcCtD
Lamivudine—Malnutrition—Docetaxel—melanoma	0.000203	0.00159	CcSEcCtD
Lamivudine—Erythema—Docetaxel—melanoma	0.000203	0.00159	CcSEcCtD
Lamivudine—Hypersensitivity—Dactinomycin—melanoma	0.000203	0.00159	CcSEcCtD
Lamivudine—Dysgeusia—Docetaxel—melanoma	0.000198	0.00155	CcSEcCtD
Lamivudine—Urticaria—Temozolomide—melanoma	0.000198	0.00155	CcSEcCtD
Lamivudine—Asthenia—Dactinomycin—melanoma	0.000197	0.00154	CcSEcCtD
Lamivudine—Abdominal pain—Temozolomide—melanoma	0.000197	0.00154	CcSEcCtD
Lamivudine—Body temperature increased—Temozolomide—melanoma	0.000197	0.00154	CcSEcCtD
Lamivudine—Back pain—Docetaxel—melanoma	0.000196	0.00153	CcSEcCtD
Lamivudine—Muscle spasms—Docetaxel—melanoma	0.000195	0.00153	CcSEcCtD
Lamivudine—Hypersensitivity—Carmustine—melanoma	0.00019	0.00148	CcSEcCtD
Lamivudine—Diarrhoea—Dactinomycin—melanoma	0.000188	0.00147	CcSEcCtD
Lamivudine—Vomiting—Bleomycin—melanoma	0.000187	0.00147	CcSEcCtD
Lamivudine—Anaemia—Docetaxel—melanoma	0.000187	0.00147	CcSEcCtD
Lamivudine—Rash—Bleomycin—melanoma	0.000186	0.00146	CcSEcCtD
Lamivudine—Dermatitis—Bleomycin—melanoma	0.000186	0.00145	CcSEcCtD
Lamivudine—Asthenia—Carmustine—melanoma	0.000185	0.00145	CcSEcCtD
Lamivudine—Hypersensitivity—Temozolomide—melanoma	0.000183	0.00143	CcSEcCtD
Lamivudine—Syncope—Docetaxel—melanoma	0.000182	0.00142	CcSEcCtD
Lamivudine—Leukopenia—Docetaxel—melanoma	0.000181	0.00142	CcSEcCtD
Lamivudine—Asthenia—Temozolomide—melanoma	0.000178	0.0014	CcSEcCtD
Lamivudine—Loss of consciousness—Docetaxel—melanoma	0.000178	0.00139	CcSEcCtD
Lamivudine—Cough—Docetaxel—melanoma	0.000177	0.00138	CcSEcCtD
Lamivudine—Diarrhoea—Carmustine—melanoma	0.000176	0.00138	CcSEcCtD
Lamivudine—Pruritus—Temozolomide—melanoma	0.000176	0.00138	CcSEcCtD
Lamivudine—Convulsion—Docetaxel—melanoma	0.000176	0.00137	CcSEcCtD
Lamivudine—Nausea—Bleomycin—melanoma	0.000175	0.00137	CcSEcCtD
Lamivudine—Vomiting—Dactinomycin—melanoma	0.000175	0.00137	CcSEcCtD
Lamivudine—Rash—Dactinomycin—melanoma	0.000173	0.00136	CcSEcCtD
Lamivudine—Arthralgia—Docetaxel—melanoma	0.000173	0.00135	CcSEcCtD
Lamivudine—Chest pain—Docetaxel—melanoma	0.000173	0.00135	CcSEcCtD
Lamivudine—Myalgia—Docetaxel—melanoma	0.000173	0.00135	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000171	0.00134	CcSEcCtD
Lamivudine—Dizziness—Carmustine—melanoma	0.00017	0.00133	CcSEcCtD
Lamivudine—Diarrhoea—Temozolomide—melanoma	0.00017	0.00133	CcSEcCtD
Lamivudine—Dry mouth—Docetaxel—melanoma	0.000169	0.00132	CcSEcCtD
Lamivudine—Confusional state—Docetaxel—melanoma	0.000167	0.00131	CcSEcCtD
Lamivudine—Oedema—Docetaxel—melanoma	0.000165	0.00129	CcSEcCtD
Lamivudine—Anaphylactic shock—Docetaxel—melanoma	0.000165	0.00129	CcSEcCtD
Lamivudine—Dizziness—Temozolomide—melanoma	0.000164	0.00129	CcSEcCtD
Lamivudine—Infection—Docetaxel—melanoma	0.000164	0.00129	CcSEcCtD
Lamivudine—Vomiting—Carmustine—melanoma	0.000164	0.00128	CcSEcCtD
Lamivudine—Nausea—Dactinomycin—melanoma	0.000163	0.00128	CcSEcCtD
Lamivudine—Shock—Docetaxel—melanoma	0.000163	0.00127	CcSEcCtD
Lamivudine—Rash—Carmustine—melanoma	0.000162	0.00127	CcSEcCtD
Lamivudine—Nervous system disorder—Docetaxel—melanoma	0.000162	0.00127	CcSEcCtD
Lamivudine—Dermatitis—Carmustine—melanoma	0.000162	0.00127	CcSEcCtD
Lamivudine—Thrombocytopenia—Docetaxel—melanoma	0.000162	0.00127	CcSEcCtD
Lamivudine—Headache—Carmustine—melanoma	0.000161	0.00126	CcSEcCtD
Lamivudine—Skin disorder—Docetaxel—melanoma	0.000161	0.00126	CcSEcCtD
Lamivudine—Vomiting—Temozolomide—melanoma	0.000158	0.00124	CcSEcCtD
Lamivudine—Anorexia—Docetaxel—melanoma	0.000158	0.00123	CcSEcCtD
Lamivudine—ABCB1—head—melanoma	0.000158	0.00287	CbGeAlD
Lamivudine—Rash—Temozolomide—melanoma	0.000157	0.00123	CcSEcCtD
Lamivudine—Dermatitis—Temozolomide—melanoma	0.000157	0.00123	CcSEcCtD
Lamivudine—Headache—Temozolomide—melanoma	0.000156	0.00122	CcSEcCtD
Lamivudine—Hypotension—Docetaxel—melanoma	0.000155	0.00121	CcSEcCtD
Lamivudine—Nausea—Carmustine—melanoma	0.000153	0.0012	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000151	0.00118	CcSEcCtD
Lamivudine—Insomnia—Docetaxel—melanoma	0.00015	0.00117	CcSEcCtD
Lamivudine—Paraesthesia—Docetaxel—melanoma	0.000149	0.00116	CcSEcCtD
Lamivudine—Nausea—Temozolomide—melanoma	0.000148	0.00116	CcSEcCtD
Lamivudine—Dyspnoea—Docetaxel—melanoma	0.000147	0.00115	CcSEcCtD
Lamivudine—Somnolence—Docetaxel—melanoma	0.000147	0.00115	CcSEcCtD
Lamivudine—Dyspepsia—Docetaxel—melanoma	0.000146	0.00114	CcSEcCtD
Lamivudine—Decreased appetite—Docetaxel—melanoma	0.000144	0.00113	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Docetaxel—melanoma	0.000143	0.00112	CcSEcCtD
Lamivudine—Fatigue—Docetaxel—melanoma	0.000143	0.00112	CcSEcCtD
Lamivudine—Pain—Docetaxel—melanoma	0.000141	0.00111	CcSEcCtD
Lamivudine—Constipation—Docetaxel—melanoma	0.000141	0.00111	CcSEcCtD
Lamivudine—Feeling abnormal—Docetaxel—melanoma	0.000136	0.00107	CcSEcCtD
Lamivudine—Gastrointestinal pain—Docetaxel—melanoma	0.000135	0.00106	CcSEcCtD
Lamivudine—Body temperature increased—Docetaxel—melanoma	0.000131	0.00102	CcSEcCtD
Lamivudine—Abdominal pain—Docetaxel—melanoma	0.000131	0.00102	CcSEcCtD
Lamivudine—Hypersensitivity—Docetaxel—melanoma	0.000122	0.000954	CcSEcCtD
Lamivudine—Asthenia—Docetaxel—melanoma	0.000119	0.000929	CcSEcCtD
Lamivudine—Pruritus—Docetaxel—melanoma	0.000117	0.000916	CcSEcCtD
Lamivudine—Diarrhoea—Docetaxel—melanoma	0.000113	0.000886	CcSEcCtD
Lamivudine—ABCB1—lymph node—melanoma	0.00011	0.00201	CbGeAlD
Lamivudine—Dizziness—Docetaxel—melanoma	0.000109	0.000856	CcSEcCtD
Lamivudine—Vomiting—Docetaxel—melanoma	0.000105	0.000823	CcSEcCtD
Lamivudine—Rash—Docetaxel—melanoma	0.000104	0.000816	CcSEcCtD
Lamivudine—Dermatitis—Docetaxel—melanoma	0.000104	0.000816	CcSEcCtD
Lamivudine—Headache—Docetaxel—melanoma	0.000104	0.000811	CcSEcCtD
Lamivudine—Nausea—Docetaxel—melanoma	9.83e-05	0.000769	CcSEcCtD
Lamivudine—NME1—Metabolism—PTEN—melanoma	1.44e-05	9.39e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—melanoma	1.44e-05	9.39e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HDAC2—melanoma	1.44e-05	9.39e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CXCR4—melanoma	1.44e-05	9.39e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FOXO4—melanoma	1.44e-05	9.39e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD44—melanoma	1.42e-05	9.29e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—VCAN—melanoma	1.42e-05	9.24e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2—melanoma	1.41e-05	9.22e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—VCAN—melanoma	1.4e-05	9.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.39e-05	9.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.37e-05	8.92e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLCB4—melanoma	1.37e-05	8.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP17A1—melanoma	1.36e-05	8.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.35e-05	8.79e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—melanoma	1.34e-05	8.74e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.34e-05	8.74e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—melanoma	1.32e-05	8.63e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.32e-05	8.62e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.32e-05	8.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT3—melanoma	1.31e-05	8.57e-05	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	1.31e-05	8.57e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CD—melanoma	1.31e-05	8.55e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ABCB1—melanoma	1.31e-05	8.52e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—VCAN—melanoma	1.31e-05	8.52e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—melanoma	1.29e-05	8.44e-05	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—melanoma	1.29e-05	8.4e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.29e-05	8.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC6A11—melanoma	1.28e-05	8.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIP4K2A—melanoma	1.28e-05	8.38e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNA11—melanoma	1.28e-05	8.36e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	1.27e-05	8.3e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—MAPK1—melanoma	1.26e-05	8.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—melanoma	1.26e-05	8.2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—FASN—melanoma	1.25e-05	8.19e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.25e-05	8.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTAP—melanoma	1.25e-05	8.15e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.25e-05	8.14e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC5A5—melanoma	1.23e-05	8.05e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—melanoma	1.23e-05	8.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.22e-05	7.98e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PRKCA—melanoma	1.2e-05	7.84e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ABCB1—melanoma	1.2e-05	7.84e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—melanoma	1.2e-05	7.83e-05	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—melanoma	1.2e-05	7.81e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP17A1—melanoma	1.19e-05	7.79e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ERCC2—melanoma	1.19e-05	7.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNAQ—melanoma	1.19e-05	7.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CD44—melanoma	1.19e-05	7.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.19e-05	7.77e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NRAS—melanoma	1.19e-05	7.74e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP17A1—melanoma	1.18e-05	7.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.18e-05	7.69e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MAPK1—melanoma	1.18e-05	7.68e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.17e-05	7.61e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB4—melanoma	1.16e-05	7.57e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.16e-05	7.54e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.15e-05	7.51e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN2B—melanoma	1.15e-05	7.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.15e-05	7.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.14e-05	7.46e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CB—melanoma	1.14e-05	7.46e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1B1—melanoma	1.14e-05	7.46e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK3—melanoma	1.14e-05	7.41e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—melanoma	1.13e-05	7.39e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNA11—melanoma	1.13e-05	7.36e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNA11—melanoma	1.12e-05	7.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PHGDH—melanoma	1.11e-05	7.26e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LUM—melanoma	1.11e-05	7.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD86—melanoma	1.11e-05	7.26e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	1.11e-05	7.22e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PRKCA—melanoma	1.11e-05	7.21e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—FASN—melanoma	1.1e-05	7.2e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP17A1—melanoma	1.1e-05	7.19e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ERCC2—melanoma	1.1e-05	7.15e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—melanoma	1.1e-05	7.14e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—melanoma	1.09e-05	7.14e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—FASN—melanoma	1.09e-05	7.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HPSE—melanoma	1.09e-05	7.12e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC5A5—melanoma	1.09e-05	7.08e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK1—melanoma	1.08e-05	7.05e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF1—melanoma	1.08e-05	7.04e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC5A5—melanoma	1.07e-05	7.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CUBN—melanoma	1.07e-05	6.99e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNAQ—melanoma	1.05e-05	6.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CD44—melanoma	1.05e-05	6.84e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PDGFRA—melanoma	1.04e-05	6.82e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNA11—melanoma	1.04e-05	6.79e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNAQ—melanoma	1.04e-05	6.77e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CD44—melanoma	1.04e-05	6.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.04e-05	6.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BSG—melanoma	1.04e-05	6.75e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SDHD—melanoma	1.04e-05	6.75e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CSPG4—melanoma	1.04e-05	6.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PRKCA—melanoma	1.03e-05	6.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERCC2—melanoma	1.03e-05	6.69e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—melanoma	1.02e-05	6.66e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—melanoma	1.02e-05	6.66e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—FASN—melanoma	1.02e-05	6.64e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—melanoma	1.02e-05	6.63e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—melanoma	1.01e-05	6.61e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAP2K2—melanoma	1.01e-05	6.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.01e-05	6.58e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1B1—melanoma	1.01e-05	6.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPAM—melanoma	1e-05	6.54e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC5A5—melanoma	1e-05	6.54e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1B1—melanoma	9.95e-06	6.49e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—melanoma	9.88e-06	6.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	9.82e-06	6.4e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNAQ—melanoma	9.68e-06	6.31e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CD44—melanoma	9.68e-06	6.31e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—melanoma	9.62e-06	6.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HLA-A—melanoma	9.62e-06	6.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RAC1—melanoma	9.59e-06	6.25e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	9.55e-06	6.23e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—melanoma	9.45e-06	6.16e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—melanoma	9.42e-06	6.14e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—melanoma	9.41e-06	6.14e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—melanoma	9.38e-06	6.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	9.34e-06	6.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	9.34e-06	6.09e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1B1—melanoma	9.28e-06	6.05e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—melanoma	9.2e-06	6e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—melanoma	9.09e-06	5.93e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.08e-06	5.92e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—melanoma	9.07e-06	5.92e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	8.9e-06	5.8e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	8.82e-06	5.76e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—melanoma	8.68e-06	5.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PRKCA—melanoma	8.66e-06	5.65e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—melanoma	8.66e-06	5.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ERCC2—melanoma	8.59e-06	5.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLA2G6—melanoma	8.52e-06	5.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—melanoma	8.36e-06	5.46e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—melanoma	8.36e-06	5.45e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—melanoma	8.3e-06	5.41e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOTCH1—melanoma	8.28e-06	5.4e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—melanoma	8.28e-06	5.4e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CD—melanoma	8.28e-06	5.4e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—melanoma	8.2e-06	5.35e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—melanoma	8.17e-06	5.33e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD80—melanoma	8.12e-06	5.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	8.11e-06	5.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KIT—melanoma	8.1e-06	5.28e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—melanoma	8.1e-06	5.28e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGF—melanoma	8.01e-06	5.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	7.84e-06	5.12e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—melanoma	7.66e-06	5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—VCAN—melanoma	7.66e-06	4.99e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—melanoma	7.64e-06	4.98e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PRKCA—melanoma	7.62e-06	4.97e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—melanoma	7.61e-06	4.97e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CD—melanoma	7.61e-06	4.97e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ERCC2—melanoma	7.56e-06	4.93e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PRKCA—melanoma	7.54e-06	4.92e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—melanoma	7.51e-06	4.9e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ERCC2—melanoma	7.48e-06	4.88e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CB—melanoma	7.22e-06	4.71e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAP2K1—melanoma	7.17e-06	4.68e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—melanoma	7.15e-06	4.67e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CD—melanoma	7.12e-06	4.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.12e-06	4.64e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PRKCA—melanoma	7.03e-06	4.59e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ERCC2—melanoma	6.97e-06	4.55e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—melanoma	6.97e-06	4.55e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF2—melanoma	6.82e-06	4.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—melanoma	6.78e-06	4.43e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CB—melanoma	6.63e-06	4.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.62e-06	4.32e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—melanoma	6.57e-06	4.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—melanoma	6.55e-06	4.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP17A1—melanoma	6.46e-06	4.21e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MDM2—melanoma	6.38e-06	4.16e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—melanoma	6.29e-06	4.1e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—melanoma	6.24e-06	4.07e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CB—melanoma	6.21e-06	4.05e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD4—melanoma	6.2e-06	4.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—melanoma	6.15e-06	4.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNA11—melanoma	6.1e-06	3.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	5.98e-06	3.9e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FASN—melanoma	5.97e-06	3.89e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—melanoma	5.97e-06	3.89e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CD—melanoma	5.96e-06	3.89e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—melanoma	5.91e-06	3.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—melanoma	5.89e-06	3.84e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A5—melanoma	5.87e-06	3.83e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—melanoma	5.83e-06	3.8e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—melanoma	5.76e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—melanoma	5.73e-06	3.74e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—melanoma	5.7e-06	3.72e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—melanoma	5.69e-06	3.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CD44—melanoma	5.67e-06	3.7e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNAQ—melanoma	5.67e-06	3.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—melanoma	5.51e-06	3.59e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—melanoma	5.5e-06	3.59e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1B1—melanoma	5.44e-06	3.55e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—melanoma	5.38e-06	3.51e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—melanoma	5.36e-06	3.5e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—melanoma	5.31e-06	3.47e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CD—melanoma	5.25e-06	3.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CB—melanoma	5.2e-06	3.39e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CD—melanoma	5.19e-06	3.39e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—melanoma	5.18e-06	3.38e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—melanoma	5.15e-06	3.36e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—melanoma	5.13e-06	3.34e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CD—melanoma	4.84e-06	3.16e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—melanoma	4.8e-06	3.13e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—melanoma	4.79e-06	3.12e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—melanoma	4.78e-06	3.12e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK3—melanoma	4.58e-06	2.99e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CB—melanoma	4.57e-06	2.98e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—melanoma	4.53e-06	2.96e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CB—melanoma	4.53e-06	2.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—melanoma	4.49e-06	2.93e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—melanoma	4.49e-06	2.93e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—melanoma	4.46e-06	2.91e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—melanoma	4.4e-06	2.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK1—melanoma	4.36e-06	2.84e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—melanoma	4.36e-06	2.84e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CB—melanoma	4.22e-06	2.75e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—melanoma	4.18e-06	2.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PRKCA—melanoma	4.12e-06	2.69e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—melanoma	4.12e-06	2.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ERCC2—melanoma	4.09e-06	2.67e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—melanoma	4.04e-06	2.64e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—melanoma	3.95e-06	2.58e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—melanoma	3.91e-06	2.55e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—melanoma	3.78e-06	2.47e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—melanoma	3.65e-06	2.38e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—melanoma	3.59e-06	2.34e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—melanoma	3.5e-06	2.28e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—melanoma	3.35e-06	2.19e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—melanoma	3.3e-06	2.16e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—melanoma	3.23e-06	2.11e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—melanoma	3.17e-06	2.07e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—melanoma	3.12e-06	2.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—melanoma	3.09e-06	2.02e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CD—melanoma	2.84e-06	1.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—melanoma	2.8e-06	1.83e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—melanoma	2.79e-06	1.82e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—melanoma	2.76e-06	1.8e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—melanoma	2.59e-06	1.69e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—melanoma	2.57e-06	1.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CB—melanoma	2.47e-06	1.61e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—melanoma	2.45e-06	1.6e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—melanoma	2.28e-06	1.49e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—melanoma	2.25e-06	1.47e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—melanoma	2.14e-06	1.39e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—melanoma	2.1e-06	1.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—melanoma	1.51e-06	9.83e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—melanoma	1.23e-06	8.03e-06	CbGpPWpGaD
